Waters Corp. 2Q Growth, Narrowed Outlook Driven By Instrument Replacement Demand

Dow Jones
2025/08/04
 

By Katherine Hamilton

 

Waters Corp. posted higher second-quarter revenue and narrowed its full-year outlook range thanks in part to strong demand for instrument replacement.

The maker of healthcare and science products on Monday posted a profit of $147.1 million, or $2.47 a share, in the second quarter, compared with $142.7 million, or $2.40 a share, a year earlier.

Stripping out certain one-time items, adjusted per-share earnings were $2.95, ahead of the $2.94 forecast by analysts, according to FactSet.

Revenue rose 8.9% to $771.3 million. Analysts surveyed by FactSet forecast revenue of $749 million.

The company raised the lower end of its full-year outlook to an adjusted earnings per share range of $12.95 to $13.05, up from $12.75 to $13.05. In the third quarter, Waters expects adjusted earnings per share to be $3.15 to $3.25.

Waters' results were driven by strong instrument replacement trends, driven by large pharmaceutical and contract development and manufacturing organization companies, Chief Executive Udit Batra said.

There was also incremental growth in its GLP-1, PFAS and generics sectors.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

August 04, 2025 06:32 ET (10:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10